AptaBio Therapeutics (Korea) Today
| 293780 Stock | 7,270 150.00 2.02% |
PerformanceModest
| Odds Of DistressBelow Average
|
AptaBio Therapeutics is trading at 7270.00 as of the 23rd of March 2025, a 2.02 percent decrease since the beginning of the trading day. The stock's open price was 7420.0. AptaBio Therapeutics has about a 36 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 23rd of December 2024 and ending today, the 23rd of March 2025. Click here to learn more.
Moving together with AptaBio Stock
Moving against AptaBio Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
AptaBio Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. AptaBio Therapeutics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding AptaBio Therapeutics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology & Medical Research (View all Sectors) |
AptaBio Therapeutics (293780) is traded on KOSDAQ in Korea and employs 2 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 111.21 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AptaBio Therapeutics's market, we take the total number of its shares issued and multiply it by AptaBio Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. AptaBio Therapeutics has 10.88 M outstanding shares.
AptaBio Therapeutics has accumulated about 6.57 B in cash with (8.9 B) of positive cash flow from operations.
Check AptaBio Therapeutics Probability Of Bankruptcy
Ownership AllocationThe market capitalization of AptaBio Therapeutics is USD111.21 Billion. AptaBio Therapeutics retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check AptaBio Ownership Details
AptaBio Therapeutics Risk Profiles
Although AptaBio Therapeutics' alpha and beta are two of the key measurements used to evaluate AptaBio Therapeutics' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.91 | |||
| Semi Deviation | 2.3 | |||
| Standard Deviation | 3.78 | |||
| Variance | 14.26 |
AptaBio Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in AptaBio Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
Other Information on Investing in AptaBio Stock
AptaBio Therapeutics financial ratios help investors to determine whether AptaBio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AptaBio with respect to the benefits of owning AptaBio Therapeutics security.